Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829699 · ClinicalTrials.gov registry record · Early Phase 1
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 31
- Enrollment target
NCT00829699 is a Early Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 31 participants.
The verdict
NCT00829699, a Early Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about why patients with diabetes have increased heart attacks, strokes and other illnesses due to blood clots causing blockage of a blood vessel. The proposed protocol will study the separate and combined effects of high glucose and high fats on certain cardiovascular responses in Type 2 DM.
Interventions
- PROCEDURE euinsulinemic euglycemic glucose clamp
- PROCEDURE euinsulinemic hyperglycemic glucose clamp
- PROCEDURE Hyperinsulinemic euglycemic glucose clamp
- PROCEDURE Hyperinsulinemic hyperglycemic glucose clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2009-07 |
| Est. Completion | 2014-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00829699
The ClinicalTrials.gov registry entry for NCT00829699 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which euinsulinemic euglycemic glucose clamp is the first listed.
NCT00829699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00829699 about?
NCT00829699 is a clinical study titled "Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus". The purpose of this study is to learn more about why patients with diabetes have increased heart attacks, strokes and other illnesses due to blood clots causing blockage of a blood vessel. The proposed protocol will study the separate and combined effects of high glucose and high fats on certain car...
What is the current status of trial NCT00829699?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 31 participants. The study started on 2009-07. Estimated completion is 2014-04.
What interventions are being tested in trial NCT00829699?
The interventions under investigation include: euinsulinemic euglycemic glucose clamp (PROCEDURE), euinsulinemic hyperglycemic glucose clamp (PROCEDURE), Hyperinsulinemic euglycemic glucose clamp (PROCEDURE), Hyperinsulinemic hyperglycemic glucose clamp (PROCEDURE).
Who is sponsoring clinical trial NCT00829699?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.